(Q46300355)

English

Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

focused ultrasound

0 references

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Kenneth Siu Ho Chok

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

author name string

Tan To Cheung

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Regina C L Lo

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Ferdinand S K Chu

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Simon H Y Tsang

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Albert C Y Chan

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

William W Sharr

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Wing Chiu Dai

9

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

See Ching Chan

10

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Sheung Tat Fan

11

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Chung Mau Lo

12

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

publication date

24 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Liver Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

20

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

912-921

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

An analysis of 412 cases of hepatocellular carcinoma at a Western center

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

High-intensity focused ultrasound in the treatment of solid tumours

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Benefit of downsizing hepatocellular carcinoma in a liver transplant population

1 reference

https://api.crossref.org/works/10.1002%2FLT.23892

21 January 2018

Identifiers

10.1002/LT.23892

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/24753206

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46300355&oldid=2104082249"